Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference

Clinical Cancer Research

Volumn 9, Issue 3, 2003, Pages 931-946

  Williams, Noelle Sevilir ^a   Gaynor, Richard B ^a,b   Scoggin, Shane ^a   Verma, Udit ^b   Gokaslan, Tunc ^c   Simmang, Clifford ^c   Fleming, Jason ^c   Tavana, Denise ^a   Frenkel, Eugene ^b   Becerra, Carlos ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVIN;

ADULT; AGED; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UNINDEXED SEQUENCE; UPREGULATION; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL DIVISION; COLORECTAL NEOPLASMS; DNA, COMPLEMENTARY; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037343270     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Cancer Facts & Figures 2002. American Cancer Society, 2002.
2. Houlston, R. S. What we could do now: molecular pathology of colorectal cancer. Mol. Pathol., 54: 206-214, 2001.
3. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
4. Grodin, J., Thliveris, A., Samowitz, W., Carlson, M., Gelber, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., and Robertson, M. Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66: 589-600, 1991.
5. Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., and Kinzler, K. W. APC mutations occur early during colorectal tumorigenesis. Nature (Lond.), 359: 235-237, 1992.
6. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature (Lond.), 382: 638-642, 1996.
7. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Wash. DC), 281: 1509-1512, 1998.
8. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R., and Ben-Ze'ev, A. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA, 96: 5522-5527, 1999.
9. Tetsu, O., and McCormick, F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999.
10. Sparks, A. B., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58: 1130-1134, 1998.
11. Haydon, A. M. M., and Jass, J. R. Emergin pathways in colorectalcancer development. Lancet, 3: 83-88, 2002.
12. Pignatelli, M., Liu, D., Nasim, M. M., Stamp, G. W., Hirano, S., and Takeichi, M. Morphoregulatory activities of E-cadherin and β-1 integrins in colorectal tumour cells. Br. J. Cancer, 66: 629-634, 1992.
13. de Bruin, P. A., Griffioen, G., Verspaget, H. W., Verheijen, J. H., Dooijewaard, G., van den Ingh, H. F., and Lamers, C. B. Plasminogen activator profiles in neoplastic tissues of the human colon. Cancer Res., 48: 4520-4524, 1988.
14. Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (Wash. DC), 270: 467-470, 1995.
15. DeRisi, J. L., Iyer, V. R., and Brown, P. O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science (Wash. DC), 278: 680-686, 1997.
16. Wu, T. D. Analysing gene expression data from DNA microarrays to identify candidate genes. J. Pathol., 195: 53-65, 2001.
17. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Jr., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Staudt, L. M., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (Lond.), 403: 503-511, 2000.
18. Garber, M. E., Troyanskaya, O. G., Schluens, D., Pertersen, S., Thaesler, Z., Pacyna-Gengelback, M., van de Rijin, M., Rosen, G. D., Perou, C. M., Whyte, R. I., Altman, R. B., Brown, P. O., Botstein, D., and Pertersen, I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 98: 13784-13789, 2001.
19. van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-536, 2002.
20. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., and Lander, E. S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash. DC), 28: 531-537, 1999.
21. Kitahara, O., Furukawa, Y., Tanaka, T., Kihara, C., Ono, K., Yanagawa, R., Nita, M. E., Takagi, T., Nakamura, Y., and Tsunoda, T. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res., 61: 3544-3549, 2001.
22. Notterman, D. A., Alon, U., Sierk, A. J., and Levine, A. J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res., 61: 3124-3130, 2001.
23. Hegde, P., Qi, R., Gaspard, R., Abernathy, K., Dharap, S., Earle-Hughes, J., Gay, C., Nwokekeh, N. U., Chen, T., Saeed, A. I., Sharov, V., Lee, N. H., Yeatman, T. J., and Quackenbush, J. Identification of tumor markers in models of human colorectal cancer using a 19, 200-element complementary DNA microarray. Cancer Res., 61: 7792-7797, 2001.
24. Clark, E, A., Golub, T. R., Lander, E. S., and Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature (Lond.), 406: 532-535, 2000.
25. Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T., and Weber, K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci., 114: 4557-4565, 2001.
26. Dudley, N. R., Labbe, J. C., and Goldstein, B. Using RNA interference to identify genes required for RNA interference. Proc. Natl. Acad. Sci. USA, 99: 4191-4196, 2002.
27. Caplen, N. J., Parrish, S., Imani, F., Fire, A., and Morgan, R. A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA, 98: 9742-9747, 2001.
28. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond.), 411: 494-498, 2001.
29. Brattain, M. G., Fine, W. D., Khaled, F. M., Thompson, J., and Brattain, D. E. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res., 41: 1751-1756, 1981.
30. Schageman, J. J., Basit, M., Gallardo, T. D., Garner, H. R., and Shohet, R. V. MarC-V: a spreadsheet-based tool for analysis, normalization, and visualization of single cDNA microarray experiments. Biotechniques, 32: 338-344, 2002.
31. Shirasawa, S., Furuse, M., Yokoyama, N., and Sasazuki, T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science (Wash. DC), 260: 85-88, 1993.
32. Ilyas, M., Tomlinson, I. P., Rowan, A., Pignatelli, M., and Bodmer, W. F. β-Catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. USA, 94: 10330-10334, 1997.
33. Lu, X., Errington, J., Curtin, N. J., Lunec, J., and Newell, D. R. The impact of p53 status on cellular sensitivity to antifolate drugs. Clin. Cancer Res., 7: 2114-2123, 2001.
34. Ambrosini, G., Adida, C., and Altieri, D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med., 3: 917-921, 1997.
35. Kawasaki, H., Toyoda, M., Shinohara, H., Okuda, J., Watanabe, I., Yamamoto, T., Tanaka, K., Tenjo, T., and Tanigawa, N. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer (Phila.), 91: 2026-2032, 2001.
36. Bao, R., Connolly, D. C., Murphy, M., Green, J., Weinstein, J. K., Pisarcik, D. A., and Hamilton, T. C. Activation of cancer-specific gene expression by the survivin promoter. J. Natl. Cancer Inst., 94: 522-528, 2002.
37. Ambrosini, G., Adida, C., Sirugo, G., and Altieri, D. C. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem., 273: 11177-11182, 1998.
38. Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., and Altieri, D. C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature (Lond.), 396: 580-584, 1998.
39. Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., and Altieri, D. C. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol., 1: 461-466, 1999.
40. Jansen-Durr, P., Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, J., Wessbecher, J., Draetta, G., and Eilers, M. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA, 90: 3685-3689, 1993.
41. 1 cyclin-cdk complexes. EMBO J., 14: 4814-4826, 1995.
42. Leone, G., DeGregori, J., Sears, R., Jakoi, L., and Nevins, J. R. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature (Lond.), 387: 422-426, 1997.
43. Schuhmacher, M., Staege, M. S., Pajic, A., Polack, A., Weidle, U. H., Bornkamm, G. W., Eick, D., and Kohlhuber, F. Control of cell growth by c-Myc in the absence of cell division. Curr. Biol., 9: 1255-1258, 1999.
44. Iritani, B. M., and Eisenman, R. N. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl. Acad. Sci. USA, 96: 13180-13185, 1999.
45. Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N., and Gallant, P. Drosophila myc regulates cellular growth during development. Cell, 98: 779-790, 1999.
46. Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Gene expression profiles in normal and cancer cells. Science (Wash. DC), 276: 1268-1272, 1997.
47. Alon, U., Barkai, N., Notterman, D. A., Gish, K., Ybarra, S., Mack, D., and Levine, A. J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. USA, 96: 6745-6750, 1999.
48. Buckhaults, P., Rago, C., St Croix, B., Romans, K. E., Saha, S., Zhang, L., Vogelstein, B., and Kinzler, K. W. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res., 61: 6996-7001, 2001.
49. Saha, S., Bardelli, A., Buckhaults, P., Velculescu, V. E., Rago, C., St Croix, B., Romans, K. E., Choti, M. A., Lengauer, C., Kinzler, K. W., and Vogelstein, B. A phosphatase associated with metastasis of colorectal cancer. Science (Wash. DC), 294: 1343-1346, 2001.
50. Fujita, M., Furukawa, Y., Tsunoda, T., Tanaka, T., Ogawa, M., and Nakamura, Y. Up-regulation of the ectodermal-neural cortex 1 (ENC 1) gene, a downstream target of the β-catenin/T-cell factor complex, in colorectal carcinomas. Cancer Res., 61: 7722-7726, 2001.
51. Lin, Y. M., Ono, K., Satoh, S., Ishiguro, H., Fujita, M., Miwa, N., Tanaka, T., Tsunoda, T., Yang, K. C., Nakamura, Y., and Furukawa, Y. Identification of AF17 as a downstream gene of the β-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis. Cancer Res., 61: 6345-6349, 2001.
52. Takemasa, I., Higuchi, H., Yamamoto, H., Sekimoto, M., Tomita, N., Nakamori, S., Matoba, R., Monden, M., and Matsubara, K. Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer. Biochem. Biophys. Res. Commun., 285: 1244-1249, 2001.
53. Sala, A., and Watson, R. B-myb protein in cellular prolifeation, transcription control, and cancer: latest developments. J. Cell. Physiol., 179: 245-250, 1999.
54. Hibi, K., Liu, Q., Beaudry, G. A., Madden, S. L., Westra, W. H., Wehage, S. L., Yang, S. C., Heitmiller, R. F., Bertelsen, A. H., Sidransky, D., and Jen, J. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res., 58: 5690-5694, 1998.
55. van Dekken, H., Geelen, E., Dinjens, W. N., Wijnhoven, B. P., Tilanus, H. W., Tanke, H. J., and Rosenberg, C. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res., 59: 748-752, 1999.
56. Martoglio, A. M., Tom, B. D., Starkey, M., Corps, A. N., Charnock-Jones, D. S., and Smith, S. K. Changes in tumorigenesis- and anglogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays. Mol. Med., 6: 750-765, 2000.
57. Forozan, F., Mahlamaki, E. H., Monni, O., Chen, Y., Veldman, R., Jiang, Y., Gooden, G. C., Ethier, S. P., Kallioniemi, A., and Kallioniemi, O. P. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res., 60: 4519-4525, 2000.
58. Kazmierczak, B., Dal Cin, P., Wanschura, S., Borrmann, L., Fusco, A., Van den Berghe, H., and Bullerdiek, J. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer, 23: 279-285, 1998.
59. Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell, 108: 171-182, 2002.
60. Kapp, L. N., Painter, R. B., Yu, L. C., van Loon, N., Richard, C. W., 3rd, James, M. R., Cox, D. R., and Murnane, J. P. Cloning of a candidate gene for ataxia-telangiectasia group D. Am. J. Hum. Genet., 51: 45-54, 1992.
61. Murnane, J. P., and Schwartz, J. L. Cell checkpoint and radiosensitivity. Nature (Lond.), 365: 22, 1993.
62. Hatse, S., De Clercq, E., and Balzarini, J. Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation. Biochem. Pharmacol., 58: 539-555, 1999.
63. Genchev, D. D. Activity of cytidine triphosphate synthetase in normal and neoplastic tissues. Experientia, 29: 789-790, 1973.
64. Su, L. K., Burrell, M., Hill, D. E., Gyuris, J., Brent, R., Wiltshire, R., Trent, J., Vogelstein, B., and Kinzler, K. W. APC binds to the novel protein EB1. Cancer Res., 55: 2972-2977, 1995.
65. Berrueta, L., Kraeft, S. K., Tirnauer, J. S., Schuyler, S. C., Chen, L. B., Hill, D. E., Pellman, D., and Bierer, B. E. The adenomatous polyposis coli-binding protein EB1 is associated with cytoplasmic and spindle microtubules. Proc. Natl. Acad. Sci. USA, 95: 10596-10601, 1998.
66. Zhang, T., Otevrel, T., Gao, Z., Ehrlich, S. M., Fields, J. Z., and Boman, B. M. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res., 61: 8664-8667, 2001.
67. Vazquez, F., Hastings, G., Ortega, M. A., Lane, T. F., Oikemus, S., Lombardo, M., and Iruela-Arispe, M. L. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J. Biol. Chem., 274: 23349-23357, 1999.
68. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3: 673-682, 1995.
69. Kunath, T., Ordonez-Garcia, C., Turbide, C., and Beauchemin, N. Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene, 11: 2375-2382, 1995.
70. Luo, W., Tapolsky, M., Earley, K., Wood, C. G., Wilson, D. R., Logothetis, C. J., and Lin, S. H. Tumor-suppressive activity of CD66a in prostate cancer. Cancer Gene Ther., 6: 313-321, 1999.
71. Neumaier, M., Paululat, S., Chan, A., Matthaes, P., and Wagener, C. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc. Natl. Acad. Sci. USA, 90: 10744-10748, 1993.
72. Kivela, A. J., Saarnio, J., Karttunen, T. J., Kivela, J., Parkkila, A. K., Pastorekova, S., Pastorek, J., Waheed, A., Sly, W. S., Parkkila, T. S., and Rajaniemi, H. Differential expression of cytoplasmic carbonic anhydrases. CA I and II, and membrane-associated isozymes, CA IX and XII, in normal mucosa of large intestine and in colorectal tumors. Dig. Dis. Sci., 46: 2179-2186, 2001.
73. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., and Cobb, M. H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev., 22: 153-183, 2001.
74. Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., Pergamenschikov, A., Lee, J. C., Lashkari, D., Shalon, D., Myers, T. G., Weinstein, J. N., Botstein, D., and Brown, P. O. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet., 24: 227-235, 2000.
75. O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., and Altieri, D. C. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA, 97: 13103-13107, 2000.
76. Kawasaki, H., Altieri, D. C., Lu, C. D., Toyoda, M., Tenjo, T., and Tanigawa, N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res., 58: 5071-5074, 1998.
77. Erisman, M. D., Litwin, S., Keidan, R. D., Comis, R. L., and Astrin, S. M. Noncorrelation of the expression of the c-myc oncogene in colorectal carcinoma with recurrence of disease or patient survival. Cancer Res., 48: 1350-1355, 1988.
78. Evan, G., and Littlewood, T. A matter of life and cell death. Science (Wash. DC), 281: 1317-1322, 1998.
79. Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., and Conklin, D. S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev., 16: 948-958, 2002.
80. Sui, G., Soohoo, C., Affar el, B., Gay, F., Shi, Y., and Forrester, W. C. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA, 99:5515-5520, 2002.